Java Essentials Volume 2 provides structured pathway from Java fundamentals to advanced application development ...

Java 26, due in March with structured concurrency, lazy constants, AOT object caching, and primitive types in patterns, instanceof, and switch, has entered a second rampdown phase for bug fixes. Java ...

An important milestone has been achieved in brain-computer interface (BCI) technology. A new peer-reviewed study published in Nature Biomedical Engineering shows how a high-performance brain-computer ...

Like many people during the COVID pandemic, Neta Alexander began spending much of her time online: teaching on Zoom, streaming films, holding video calls with friends. The longer she did, the more she ...

Microsoft has released Proxy 4, an update of its Proxy library for runtime polymorphism in the C++ language. The new release introduces building blocks for composing facades, aliases to express ...

SAP SE today addressed two newly disclosed vulnerabilities in its SAP Graphical User Interface client applications following their discovery in coordinated research by Pathlock Inc. and Fortinet Inc.

Jony Ive’s long era of flat design is dead. At WWDC 2025 today, Apple ushered in “Liquid Glass,” a new interface for iOS 26 (all of Apple’s software platforms are jumping straight to “26”) modeled ...

We identify Bcl-2-interacting killer (BIK) as a critical host factor for influenza A virus (IAV) replication, revealing an IAV–BIK–β5 axis. This axis demonstrates how the viral nucleoprotein ...

NLWeb is an open project developed by Microsoft that aims to make it simple to create a rich, natural language interface for websites using the model of their choice and their own data. Our goal is ...

Apple is in the early stages of developing brain-computer interfaces that would allow people, especially those with mobility issues, to control their iPhones, iPads, and Vision Pro headsets with ...

Colorectal cancer is a leading cause of cancer related deaths among patients worldwide, necessitating the development of more effective and tolerable therapies. Topoisomerase I inhibitors such as ...